He talks about his latest research paper in which his team used machine learning to develop a risk-stratification model to predict which patients would experience upper gastrointestinal bleeding and then...
Dr Karpouzas talks about his research on highly sensitive cardiac troponin-I and IgA antibodies against β-2 glycoprotein 1 in the setting of coronary atherosclerosis among patients with rheumatoid...
In this podcast, Dr Charvet and Dr Eilam-Stock discuss the findings from their study, which provided evidence of early neuropsychological markers of cognitive involvement among patients with multiple...
After analyzing data from his own community teaching hospital, Arnold Markowitz, MD, suggests that the recently updated guideline for the treatment of community-acquired pneumonia be revisited from a local...
In this podcast, Steffanie A. Strathdee, PhD, discusses the lessons learned from the Vancouver HIV outbreak, how needle exchange programs are not doing enough, the changing face of the HIV epidemic,...
She discusses pharmacologic and behavioral interventions for the management of knee osteoarthritis, as well as findings from her recent study on gait speed among adults with knee osteoarthritis.
She speaks about her recent systematic review and meta-analysis that aimed to determine the risk of adverse maternal, placental, and obstetric outcomes in women with inflammatory bowel disease.
In this podcast, William R. Hiatt, MD, provides insight into a new subgroup analysis of the VOYAGER-PAD trial, which revealed whether adding clopidogrel to the rivaroxaban and aspirin regime of a patient...
Jim Oates, MD, and Joy Buie, PhD, MSCR, from The Medical University of South Carolina, discuss their research on nitric oxide synthase as a potential target for vascular disease among individuals with...
